Amarin Corporation PLC (AMRN) Reports Second Quarter 2012 Financial Results and Provides Update on Operations  
8/9/2012 10:18:40 AM

BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 8, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the quarter ended June 30, 2012 and provided an update on company operations.